MENU

BLRX Stock Tickeron detected bullish Stock Pattern: Three Rising Valleys BLRX on September 09, 2025, netting in a 1.11% gain over 2 weeks

A.I.dvisor
at Tickeron.com
Loading...
+1.11% Gain from a Successful pattern Three Rising Valleys
BLRX - BioLineRx Ltd
Tickeron
Ticker: BLRX
Company: BioLineRx
Gain: +1.11%
Confirmed: 09/09/25
Succeeded: 09/09/25
Total length: 14 days
On August 26, 2025, A.I.dvisor detected a Three Rising Valleys Pattern (Bullish) for BioLineRx Ltd (BLRX, $3.61). On September 09, 2025, A.I.dvisor confirmed the Bullish pattern, setting a target price of $4.32. On September 09, 2025, BLRX reached the target price resulting in a for traders who took a long position in the stock.

BLRX's RSI Indicator climbs out of oversold territory

The RSI Oscillator for BLRX moved out of oversold territory on August 11, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 35 similar instances when the indicator left oversold territory. In of the 35 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 10, 2025. You may want to consider a long position or call options on BLRX as a result. In of 80 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for BLRX just turned positive on August 18, 2025. Looking at past instances where BLRX's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .

BLRX moved above its 50-day moving average on September 12, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where BLRX advanced for three days, in of 247 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 71 cases where BLRX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BLRX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

BLRX broke above its upper Bollinger Band on September 10, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.858) is normal, around the industry mean (20.731). P/E Ratio (0.000) is within average values for comparable stocks, (53.474). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.171). Dividend Yield (0.000) settles around the average of (0.043) among similar stocks. P/S Ratio (0.692) is also within normal values, averaging (337.655).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. BLRX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BLRX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
BLRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information

General Information

a clinical-stage biopharmaceutical development company

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
2 HaMa’ayan Street
Phone
+972 86429100
Employees
79
Web
https://www.biolinerx.com